Gil Pharmaceutical Corp. v. Advanced Generic Corporation

CourtDistrict Court, D. Puerto Rico
DecidedMarch 22, 2021
Docket3:20-cv-01184
StatusUnknown

This text of Gil Pharmaceutical Corp. v. Advanced Generic Corporation (Gil Pharmaceutical Corp. v. Advanced Generic Corporation) is published on Counsel Stack Legal Research, covering District Court, D. Puerto Rico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gil Pharmaceutical Corp. v. Advanced Generic Corporation, (prd 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

GIL PHARMACEUTICAL CORP.,

Plaintiff,

v.

ADVANCED GENERIC CORPORATION et al., CIVIL NO. 20-1184 (PAD)

Defendant,

MEMORANDUM AND ORDER

Delgado-Hernández, District Judge. Before the court are “Defendants’ Motion to Transfer This Action to the Southern District of Florida, Pursuant to 28 U.S.C. § 1404(A) and 1406” (Docket No. 6); plaintiff’s “Request for Jurisdictional Discovery Regarding Personal Capacity Defendants and Opposition to Defendants’ Motion to Transfer this Action to the Southern District of Florida…” (Docket No. 14); defendants’ reply at Docket No. 15; plaintiff’s surreply at Docket No. 17; and defendants’ “Opposition to Plaintiff’s Motion for Jurisdictional Discovery” (Docket No. 18). For the reasons explained below, the request for jurisdictional discovery is DENIED and the request to dismiss the claims against the individual defendants at Docket No. 6 GRANTED, albeit without prejudice. Also, because the request to transfer the case to the Southern District of Florida is predicated on the inclusion of the individual defendants in this case, the request is DENIED AS MOOT. Page 2

I. FACTUAL BACKROUND1 Plaintiff, Gil Pharmaceutical Corporation (“GPC”), initiated this action in the Ponce Part of the Court of First Instance of Puerto Rico against Advanced Generic Corporation (“AGC”), José J. Hernández, his wife Karen Llorens (both identified in the complaint as shareholders and high- ranking executives of AGS and residents of Florida) and the legal conjugal partnership between them (Docket Nos. 1-1 and 7).2 Basically, it alleged that defendants violated Puerto Rico’s Trademark Law, P.R. Laws Ann. tit. 10 §§ 223-224b,3 by selling pharmaceutical products under the names of “Biotect Plus So” and “Igualtuss,” as equivalents of GPC’s registered products “Protect Plus So” and “Giltuss,” and marketing them with the labels “Compare to Protect Plus So” and “Compare to Giltuss” even though those products do not contain the same milligrams, ingredients, and production control. Id. at ¶ 9, 15, 20, 22.4 In its view, this creates a “highly dangerous situation for the health of consumers, to whom in many drugstores, internet, supermarket and other establishments where [Gil’s] products are sold, upon information and belief medication is being sold to them which is not equivalent to that recommended or marketed by physicians and other marketing teams.” Id. at ¶ 22.

1 In 2010, plaintiff filed a complaint against the corporate defendant alleging it was selling pharmaceutical products under marks or labels confusingly similar to the markings registered by trademark to plaintiff. See, Gil Pharmaceutical Corp. v. Advanced Generic Corporation et al., Civil No. 10-1074 (MEL). The parties reached a settlement agreement, and the complaint was dismissed with prejudice. Id. at Docket Nos. 79 and 80.

2 Although the Hernández-Llorens conjugal partnership appears as a defendant in the caption of the complaint, a perusal of the complaint shows there is no cause of action alleged against it.

3 The complaint invokes violation of the Puerto Rico Trademark Law, referring generally to P.R. Laws Ann. tit. 10 § 171k. That law, however, was amended by Law 169 of December 16, 2009 and is now codified in sections 223- 224b of title 10.

4 As alleged in the complaint, “Protect Plus So” is a nutritional supplement composed of multivitamins, antioxidants, bioflavonoids, chelated minerals, amino acids, and enzymes which “enjoys great fame, recognition, reputation and success in the Puerto Rico market among other formulations by experts in the market” (Docket No. 7, Exh. 1 at ¶ 13). Giltuss, in turn, is an antitussive, expectorant and decongestant which “enjoys great fame, recognition, reputation and success in the Puerto Rico market, among other formulations by experts in the field.” Id. at ¶ 18. Page 3

Defendants removed the case to this court on diversity grounds (Docket No. 1) and requested that the case be transferred to the Southern District of Florida, claiming this court lacks personal jurisdiction over three of the four named defendants – that is, the individual defendants and the conjugal partnership (Docket No 6). They added that, even accepting as true the allegations of the complaint, the individual defendants reside in the State of Florida and, therefore, are not subject to personal jurisdiction in Puerto Rico. Id.5 From their perspective, the Southern District of Florida would be the proper venue as one with personal jurisdiction over all the defendants. In the alternative, they asked for dismissal of the claims against Mr. Hernández, Mrs. Llorens and the Hernández-Llorens legal conjugal partnership, reiterating their stand that the court lacks personal jurisdiction over them. (Docket No. 6).6 GPC opposed the requests and moved for jurisdictional discovery (Docket No. 14).7 It stated that jurisdictional discovery is needed to gather the “necessary evidence to properly refute defendants’ allegations that they have no minimum contacts with Puerto Rico.” Id. at p. 6. To that end, it proffered that AGC has appeared in cases that have been litigated in Puerto Rico courts. Id. And it maintains that it is entitled to know if the individual defendant’s livelihood is, in large part, dependent on AGC’s activities in Puerto Rico. Id. In the alternative, it requested ten days to

5 According to the complaint, AGC is organized under the laws of the State of Florida, with principal offices in San Juan, P.R. 00920, and is registered in the Department of State of Puerto Rico as a foreign corporation (Docket No. 7- 1, ¶ 3). Also, it states that Mr. Hernández and Mrs. Llorens are residents of Miami, Florida. Id. at ¶¶ 4-5.

6 Defendants’ requests are predicated on the inclusion of Mr. Hernández and Mrs. Llorens as defendants in this case. They do not question that Puerto Rico would be the proper venue had the complaint only listed AGC as a defendant. In fact, in their submissions they admit that “the court’s jurisdiction over the corporate defendant is not in dispute.” (Docket No. 15, p. 2; Docket No. 18, p. 1).

7 GPC’s motion is not a model of clarity. It refers interchangeably to “defendant” (Docket No. 14, pp. 5-6), “defendants” (id. at pp. 1, 2, 4, 5), and the “corporation” (id. at p. 5) without any elaboration as to whether the arguments are directed to the individual defendants’ claims of lack of jurisdiction, or the court’s jurisdiction over the corporation. Page 4

properly oppose defendants’ motion to dismiss the claims against the individual defendants for lack of jurisdiction. Id. at p. 5-7.8 Defendants took exception to GPC’s request to conduct jurisdictional discovery and submitted two “Unsworn Declaration[s] Under Penalty of Perjury” (Docket No. 18, Exhs. 1 and 2).9 They pointed out that, although the court has discretion to allow discovery, the request for discovery should be predicated on some basis. Id. at p. 4. And they contend there is no allegation in the complaint that supports or even suggests that the court has personal jurisdiction over them.10 Id. at pp. 4-6. II. DISCUSSION A. Decisional Framework The Due Process Clause of the Fourteenth Amendment requires that in order to subject a defendant to a judgment in personam if he is not present within the forum state, he have certain minimum contacts with the state such that maintenance of the suit “not offend traditional notions of fair play and substantial justice.” Baskin-Robbins Franchising LLC v. Alpenrose Diary, 825 F.3d 28, 35 (1st Cir. 2016).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Gil Pharmaceutical Corp. v. Advanced Generic Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gil-pharmaceutical-corp-v-advanced-generic-corporation-prd-2021.